MC1R Variants May Increase Melanoma Risk, Even Without Sun Exposure

This article originally appeared here.
<i>MC1R</i> Variants May Up Melanoma Risk, Even Without Sun Exposure
MC1R Variants May Up Melanoma Risk, Even Without Sun Exposure

(HealthDay News) -- Genetics could play a role in the development of melanoma even for skin without extensive sun exposure, according to a study published online April 6 in JAMA Dermatology.

The new study, which took place in Austria, was led by Judith Wendt, M.D., Ph.D., from the Medical University of Vienna. Her team examined variations in the melanocortin-1 receptor (MC1R) gene, which affects skin pigmentation. Wendt's team examined the genes of nearly a thousand patients with melanoma and 800 similar individuals who didn't have the skin cancer. The average age of participants was 59 years, and there were roughly equal numbers of men and women.

The investigators found that 47 percent of those with melanoma reported more than 12 sunburns in their lives, compared to 31 percent of the others, showing that sun exposure is key to the disease. However, the team also found that 41 percent of the melanoma patients had two or more variants of the gene, compared to just 29 percent of the others.

According to the study authors, the findings raise questions about whether people with the gene variations are at higher risk for melanoma, regardless of their sun exposure.

Abstract
Full Text
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs